Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Link opens in a new tab
Search content at University of Birmingham
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
The neurobiology and treatment of restless legs syndrome
Ruth Jones
,
Andrea Eugenio Cavanna
Birmingham Medical School
Research output
:
Contribution to journal
›
Review article
›
peer-review
14
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The neurobiology and treatment of restless legs syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Restless Legs Syndrome
100%
Neurobiology
100%
Neurotransmitter Systems
33%
Pathophysiology
16%
Neurological Disorders
16%
Therapeutic Efficacy
16%
Methodological Limitations
16%
Basal Ganglia
16%
Neuroimaging
16%
Autopsy
16%
Health-related Quality of Life
16%
Pharmacotherapy
16%
Iron Deficiency
16%
Therapeutic Effectiveness
16%
Neuroanatomical
16%
Neuroimaging Studies
16%
Iron Metabolism
16%
Converging Evidence
16%
Disabling Conditions
16%
Metabolic Alterations
16%
Iron Supplementation
16%
Dopamine Dysregulation Syndrome
16%
Dopamine Dysfunction
16%
Opioid Medication
16%
Neuropharmacological
16%
Opioid System
16%
Medicine and Dentistry
Restless Legs Syndrome
100%
Neurotransmitter
33%
Drug Therapy
16%
Pathophysiology
16%
Quality of Life
16%
Combination Therapy
16%
Supplementation
16%
Neurologic Disease
16%
Dopamine Agonist
16%
Iron Metabolism
16%
Iron Deficiency
16%
Iron
16%
Basal Ganglia
16%
Neuroscience
Restless Legs Syndrome
100%
Neuroscience
100%
Neurotransmitter
33%
Nervous System Disorder
16%
Basal Ganglia
16%
Dopamine Agonist
16%
Iron Metabolism
16%
Drug Therapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Restless Legs Syndrome
100%
Neurotransmitter
33%
Iron
33%
Combination Therapy
16%
Dopamine Receptor Stimulating Agent
16%
Neurologic Disease
16%
Pathophysiology
16%
Pharmacotherapy
16%
Opiate Receptor
16%
Iron Deficiency
16%